Researchers identified protein markers in inherited frontotemporal dementia (FTD) patients, potentially enabling earlier diagnosis, better treatments, and improved clinical trial enrollment. RNA regulation is key.
New nanofiber therapy traps toxic amyloid-beta proteins linked to Alzheimer's, ALS, and other neurodegenerative diseases. The unstable nanofibers bind and incorporate the proteins, preventing aggregation and delaying disease progression.
Research shows ATP, the cell's 'fuel', unexpectedly impacts neurodegenerative diseases like Alzheimer's & Parkinson's. ATP controls protein solubility and viscosity, preventing harmful protein aggregation. Increasing ATP may help.
